prikaz prve stranice dokumenta Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review
No public access
Scientific paper - Review paper
Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review
Clinical Microbiology and Infection, 28 (2022), 3; 362-370. https://doi.org/10.1016/j.cmi.2021.10.001
Ioannou, Petros; Karakonstantis, Stamatis; Schouten, Jeroen; Kostyanev, Tomislav; Charani, Esmita; Vlahović-Palčevski, Vera; Kofteridis, Diamantis P.

Cite this document

Ioannou, P., Karakonstantis, S., Schouten, J., Kostyanev, T., Charani, E., Vlahović Palčevski, V. & Kofteridis, D. P. (2022). Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review. Clinical Microbiology and Infection, 28. (3), 362-370. doi: 10.1016/j.cmi.2021.10.001

Ioannou, Petros, et al. "Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review." Clinical Microbiology and Infection, vol. 28, no. 3, 2022, pp. 362-370. https://doi.org/10.1016/j.cmi.2021.10.001

Ioannou, Petros, Stamatis Karakonstantis, Jeroen Schouten, Tomislav Kostyanev, Esmita Charani, Vera Vlahović Palčevski and Diamantis P. Kofteridis. "Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review." Clinical Microbiology and Infection 28, no. 3 (2022): 362-370. https://doi.org/10.1016/j.cmi.2021.10.001

Ioannou, P., et al. (2022) 'Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review', Clinical Microbiology and Infection, 28(3), pp. 362-370. doi: 10.1016/j.cmi.2021.10.001

Ioannou P, Karakonstantis S, Schouten J, Kostyanev T, Charani E, Vlahović Palčevski V, and sur.. Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review. Clinical Microbiology and Infection [Internet]. 2022 March [cited 2025 January 22];28(3):362-370. doi: 10.1016/j.cmi.2021.10.001

P. Ioannou, et al., "Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review", Clinical Microbiology and Infection, vol. 28, no. 3, pp. 362-370, March 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:618681. [Accessed: 22 January 2025]

Please login to the repository to save this object to your list.
Metadata
Title (english)Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review
AuthorPetros Ioannou
AuthorStamatis Karakonstantis
AuthorJeroen Schouten
AuthorTomislav Kostyanev
AuthorEsmita Charani
AuthorVera Vlahović-Palčevski
AuthorDiamantis P. Kofteridis
Author's institutionUniversity of Rijeka
Faculty of Health Studies
(Department of Basic Medical Sciences)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Basic Medical Sciences
Abstract (english)
Background: Most of the antimicrobial stewardship (AMS) literature has focused on antimicrobial consumption for the treatment of infections, for the prophylaxis of surgical site infection and for the prevention of endocarditis. The role of AMS for medical antibiotic prophylaxis (AP) has not been adequately addressed. Aims: To identify targets for AMS interventions for medical AP in adult patients. Sources: Targeted searches were conducted in PubMed. Content: The various indications for medical AP and relevant evidence from practice guidelines are outlined. The following were identified as potential targets for AMS interventions: (a) addressing under-utilization of antibiotic-sparing strategies (e.g. for recurrent urinary tract infections, recurrent soft-tissue infections, recurrent exacerbations associated with bronchiectasis or chronic obstructive pulmonary disease), (b) reducing unnecessary AP beyond recommended indications (e.g. for acute pancreatitis, bite wounds, or urinary catheter manipulations), (c) reducing the use of AP with a broader spectrum than necessary, (d) reducing the use of AP for longer than the recommended duration (e.g. AP for prevention of osteomyelitis in open fractures or AP in high-risk neutropenia), (e) evaluating the role of antibiotic cycling to prevent the emergence of resistance during prolonged AP (e.g. in recurrent urinary tract infections or prophylaxis for spontaneous bacterial peritonitis), and (f) addressing research gaps regarding appropriate indications or antibiotic regimens for medical prophylaxis. Implications: This review summarizes current trends in AP and proposes targets for AMS interventions.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleClinical Microbiology and Infection
Numberingvol. 28, no. 3, pp. 362-370
p-ISSN1198-743X
DOIhttps://doi.org/10.1016/j.cmi.2021.10.001
URN:NBNurn:nbn:hr:184:618681
Publication2022-03
Document URLhttps://linkinghub.elsevier.com/retrieve/pii/S1198743X21005693
Type of resourceText
Access conditionsClosed access
Terms of useLicence In copyright icon
Created on2024-01-15 11:27:00